Chimeric antigen receptor (CAR) T cell therapy for atherosclerosis
摘要
Foamy macrophages are central drivers of atherosclerotic plaque progression, yet no strategy exists to selectively eliminate these pathogenic cells. Here, we identify TREM2 as a conserved surface marker of foamy macrophages across human and mouse atherosclerotic tissues by integrated single-cell transcriptomic analysis. We generated TREM2-targeting chimeric antigen receptor (CAR) T cells and showed that they mediate potent, antigen-dependent cytotoxicity against TREM2-positive target cells in vitro. In a human vessel organoid system, TREM2 CAR T cells selectively depleted macrophage-like cells while preserving vascular integrity. In vivo, TREM2 CAR T-cell therapy reduced plaque area, necrotic core formation, and lesional TREM2+ macrophage accumulation in Apoe⁻/⁻, Ldlr⁻/⁻ and AAV8-PCSK9 mouse models of atherosclerosis, without affecting plasma lipid levels or inducing overt toxicity. Our results provide proof of concept that foamy macrophages are therapeutically targetable and establish cellular immunotherapy as a potential treatment for atherosclerosis.
参考文献
Libby, P. Nature 592, 524-533 (2021).
Moore, K.J., Sheedy, F.J., and Fisher, E.A. Nat Rev Immunol 13, 709-721 (2013).
De Meyer et al. Nat Rev Cardiol 21, 321-325 (2024).
Tan, S.H et al. World J Cardiol 18, 114960 (2026).
Zugasti, I et al. Signal Transduct Target Ther 10, 210 (2025).
Aghajanian, H et al. Nature 573, 430-433 (2019).
Rurik, J.G et al. Science 375, 91-96 (2022).
Amor, C et al. Nature 583, 127-132 (2020).
Yang, D et al. Sci Transl Med 15, eadd1951 (2023).
Schett, G., Mackensen, A., and Mougiakakos, D. Lancet 402, 2034-2044 (2023).
Murray, P.J., and Wynn, T.A. Nat Rev Immunol 11, 723-737 (2011).
Patterson, M.T et al. Nat Cardiovasc Res 2, 1015-1031 (2023).
Piollet, M et al. Nat Cardiovasc Res 3, 269-282 (2024).
Schwab, R.D et al. Circulation 153, 319-337. (2025).
Guo, X et al. Cell. Mol. Life Sci. 80, 137. (2023).
指标
DOI：
Submission ID：
下载次数
已发布
如何引用
下载引用
利益冲突声明
作者声明无任何需要披露的利益冲突。
Copyright
本预印本的版权持有者为作者/资助方。
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.